Catalog Advanced Search

Search by Categories
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • 2043-17: Whole Health Begins with Mental Health Education for Primary Care Providers

    Contains 5 Component(s), Includes Credits

    Presenter: Diane H Esposito PhD, ARNP, PMHCNS-BC 0.5 Contact Hours

    2043-17: Whole Health Begins with Mental Health Education for Primary Care Providers

    This presentation will present curriculum design for education of graduate non PMH students in mental health concepts.  This training includes evidence based approaches to screening, such as use of PHQ-9,and SBIRT, to support graduate primary care students in meeting the needs of their patients, and practice in integrated medical homes.


    Presenter:
      Diane H Esposito PhD, ARNP, PMHCNS-BC

    Disclosures:  The presenter and planners have no conflict of interest or commercial support to disclose.  Off-label uses will not be discussed during this presentation.


    Session Length:
      29 minutes

    Target Audience:  APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Design a curriculum for non Psychiatric Mental Health primary care providers to prepare them for practice in today's integrated behavioral medical homes, and to screen for mental health disorders.
    2. Differentiate between the role of the Psychiatric Mental Health versus non Psychiatric Mental Health primary care provider in meeting patient's mental health needs.
    3. Identify three screening tools to identify commonly occurring mental health problems, to support clinical decision making in referral to behavioral health specialists.

    Keywords:  Education, Screening Tools


    Continuing Nursing Education:
    0.5 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    APNA 31st Annual Conference
    Phoenix, Arizona
    Thursday, October 19, 2017
    3:00pm - 3:45pm

    The contact hours for this session expire:  January 1, 2021

  • 100-18: Paradigm Shift in Treating Mental Illness: Neurophysiological Approach to Prescribing

    Contains 5 Component(s), Includes Credits

    Presenter: Barbara J. Limandri, PhD, PMHCNS-BC - 1.50 pharmacology contact hours

    100-18:  Paradigm Shift in Treating Mental Illness: Neurophysiological Approach to Prescribing

    There is a strong body of evidence indicating that neurobiological changes in the brain/body contribute to psychiatric symptoms. Many of these symptoms are treated with drugs, which are chemicals designed to act on naturally occurring chemicals in the CNS (e.g., neurotransmitters) or neural structures (e.g., neurotransmitter transporters, neural membranes). Practitioners use evidence-based data when prescribing medications which are based on patients’ neurobiological changes and the drugs that target those changes. The content will be applied to a case study at the end of the session.


    Presenter:
      Barbara J. Limandri, PhD, PMHCNS-BC

    Disclosures:  The presenter and planners have no conflict of interest or commercial support to disclose. Off-label uses will be discussed during this presentation.


    Session Length:
      1 hour 27 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Describe neural circuitry of the central nervous system in differentiating neurobiological targets for psychotropic medications.
    2. Comprehend the relationship between mechanisms of action of psychotropic drugs to symptoms of psychiatric disorders.

    Keywords:  Brain Development, Behaviors and Medication, Psychopharmacology


    Continuing Nursing Education:
    1.50 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    APNA 16th Annual Clinical Psychopharmacology Institute
    Baltimore, Maryland
    Thursday, June 7, 2018
    5:00pm - 7:00pm

    The contact hours for this session expire: December 31, 2020

  • 102-18: Microbiome, Gut, Hormones, Brain Connections in Mental Health/Addictions

    Contains 5 Component(s), Includes Credits

    Presenters: Wendy A. Henderson, PhD, MSN, CRNP, FAAN; Lorenzo Leggio, MD, PhD, MSc - 1.75 pharmacology contact hours

    102-18: Microbiome, Gut, Hormones, Brain Connections in Mental Health/Addictions

    This session includes the two presentations described below.

    This nurse researcher uses plain language to explain how she studies altered gut permeability in patients with previously negative clinical findings, revealing microscopic changes in the GI tract in response to stress. She is able to demonstrate with science that chronic abdominal pain is not just “all in your head”. 
    Presenter: Wendy A. Henderson, PhD, MSN, CRNP, FAAN

    This presentation details how gut-brain axis, using the neurohormone ghrelin, is studied in addictions research. Ghrelin signals the brain for food seeking and reward, and may help to explain alcohol seeking behaviors. The goal of this research is new drug development for the treatment of addictive disorders. 
    Presenter: Lorenzo Leggio, MD, PhD, MSc

    Disclosures: Lorenzo Leggio, MD, PhD, MSc has indicated a significant financial interest or other affiliation with UK MCA and Oxford Press (honorarium) and Routeledge (book royalties). Wendy A. Henderson, PhD, MSN, CRNP, FAAN, has no conflict of interest or commercial support to disclose. Off-label uses will be discussed during this presentation. The activity planners have no conflicts of interest to disclose.

    Session Length:  1 Hour 52 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Explore the role of the microbiome-gut-brain axis in addictions and mental health.
    2. Discuss the complexity of the bidirectional communications between the brain and the periphery by providing examples from basic science and human research.

    Keywords: Gut-Brain Axis, Microbiome, Addictions, Research, Psychopharmacology


    Continuing Nursing Education:
    1.75 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    APNA 16th Annual Clinical Psychopharmacology Institute
    Baltimore, Maryland
    Friday, June 8, 2018
    9:45am - 11:45am

    The contact hours for this session expire: December 31, 2020

  • 105-18: What’s Old Could Be New Again: Recognizing the Benefits and Neuroprotective Effects of Lithium

    Contains 5 Component(s), Includes Credits

    Presenter: Mary Ann Nihart, MA, APRN, PMHCNS-BC, PMHNP-BC 1.25 pharmacology contact hours

    105-18:  What’s Old Could Be New Again: Recognizing the Benefits and Neuroprotective Effects of Lithium

    Using a case study approach, this presentation gives an overview of DSM 5 changes, indications and benefits of lithium for the treatment of Bipolar disorder. The learner will explore differences in phenotype related to efficacy of this old medication option. 


    Presenter:
      Mary Ann Nihart, MA, APRN, PMHCNS-BC, PMHNP-BC

    Disclosures:  The presenter and planners have no conflict of interest or commercial support to disclose.  Off-label uses will not be discussed during this presentation.


    Session Length:
      1 hour 20 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Describe cellular mechanisms of the actions of lithium.
    2. Explore potential mechanisms of effectiveness and loss of effect in the use of lithium.

    Keywords:  APRN Practice, Psychopharmacology


    Continuing Nursing Education:
    1.25 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    APNA 16th Annual Clinical Psychopharmacology Institute
    Baltimore, Maryland
    Friday, June 8, 2018
    4:00pm - 5:30pm


    The contact hours for this session expire: December 31, 2020

  • 2065-18: APNA Administrative Council Interactive Panel

    Product not yet rated Contains 5 Component(s), Includes Credits

    Presenters: Suzie Marriott, MS, BSN, RN-BC; Kristen Kichefski, MSN, MBA, RN-BC 1.0 contact hours

    2065-18: APNA Administrative Council Interactive Panel

    The purpose of this session is to address current issues facing psychiatric nurse administrators. Results of the administrative panel survey will be presented as well as resources and a summary of a literature search, to support the priority issues identified by survey respondents.


    Presenters:
      Suzie Marriott, MS, BSN, RN-BC; Kristen Kichefski, MSN, MBA, RN-BC

    Disclosures:  The presenters and planners have no conflict of interest or commercial support to disclose.  Off-label uses will not be discussed during this presentation.


    Session Length:
      54 minutes

    Target Audience:  RN, APRN


    Learning Outcome:
    Upon completion of this presentation, the participant will be able to:

    • Identify the current issues facing psychiatric nurse administrators and strategies to address the needs of the changing PMH workforce.

    Keywords:  Nurse Administrators, RN Development, Leadership


    Continuing Nursing Education:
    1.0 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    APNA 32nd Annual Conference
    Columbus, Ohio
    Thursday, October 25, 2018
    5:00pm - 6:30pm

    The contact hours for this session expire:  December 31, 2020

  • 201-19: Managing Pharmacologic Treatment for Older Adults: Benzodiazepines and Antipsychotics

    Contains 5 Component(s), Includes Credits

    Presenter: Elizabeth Galik, PhD, CRNP, FAAN, FAANP 1.5 pharmacology contact hours

    201-19:  Managing Pharmacologic Treatment for Older Adults:  Benzodiazepines and Antipsychotics

    Focus on deprescribing benzodiazepines and antipsychotics when managing anxiety and agitation in older adults, explore alternative pharmacological options, and understand how to use these medications appropriately and safely when necessary.


    Presenter:
       Elizabeth Galik, PhD, CRNP, FAAN, FAANP

    Disclosures:  The presenter and planners have no conflict of interest or commercial support to disclose. Off-label use of medications will be discussed during this presentation.


    Session Length:
      1 hour 31 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Formulate treatment plans to address appropriate deprescribing practices of benzodiazepines and antipsychotics when used with older adults.
    2. Describe appropriate and safe prescribing practices of benzodiazepines and antipsychotics when used with older adults.

    Keywords:  Psychopharmacology, Older Adults, APRN Practice, Pharmacology


    Continuing Nursing Education:
    1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented 
    APNA 17th Annual Clinical Psychopharmacology Institute
    Louisville, KY
    Saturday, June 8, 2019
    8:00am - 9:30am


    The contact hours for this session expire:  June 30, 2021

  • 100-19: Deep Dive into Neurotransmitters: Focus on Glutamate and Gaba

    Product not yet rated Contains 5 Component(s), Includes Credits

    Presenter: Debbie Thomas, Edd, APRN, PMHNP-BC, PMHCNS-BC, CMP 1.5 pharmacology contact hours

    100-19:  Deep Dive into Neurotransmitters: Focus on Glutamate and Gaba

    This course explores neurotransmitters, particularly glutamate and GABA, from a psychopharmacological perspective. This provides a better understanding of how this neurobiology relates to the lived experience of persons with mental health disorders.


    Presenter: 
    Debbie Thomas, Edd, APRN, PMHNP-BC, PMHCNS-BC, CMP

    Disclosures: The speaker has indicated a significant financial interest or other affiliation with Assurex Health, Inc. and Allergan, Inc. Off-label uses will not be discussed during this presentation. The activity planners have no conflicts of interest to disclose.


    Session Length:
      1 hour 25 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Describe the basic difference in the major neurotransmitters in mental health.
    2. Explain how GABA and glutamate play a role in mental health disorders from a humanistic patient perspective.

    Keywords:  Neurotransmitters, Psychopharmacology


    Continuing Nursing Education:
    1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    17th Annual Clinical Psychopharmacology Institute
    Louisville, KY
    Thursday, June 6, 2019
    5:00pm - 7:00pm


    The contact hours for this session expire:  June 30, 2021

  • 101-19: New Evidence, New Delivery Methods, New Opportunities for Engaging Clients

    Contains 5 Component(s), Includes Credits

    Presenter: Rebecca S. Roma MD, MBA 1.5 pharmacology contact hours

    101-19:  New Evidence, New Delivery Methods,  New Opportunities for Engaging Clients

    Consider cutting edge scientific discoveries for treating schizophrenia. Update your background knowledge of the long-range costs, and the treatment options for this mental illness.


    Presenter:
      Rebecca S Roma MD, MBA

    Disclosures: The speaker has indicated a significant financial interest or other affiliation with Alkermes, Janssen Pharmaceuticals Inc., Neurocrine, Teva, and Otsuka America Pharmaceutical, Inc. Off-label uses will not be discussed during this presentation. The activity planners have no conflicts of interest to disclose.


    Session Length:
      1 hour 24 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Describe the course, continuity of care, and costs of schizophrenia.
    2. Explore oral medications and LAIs in a new paradigm for treatment of schizophrenia.

    Keywords:  Psychopharmacology, Long Acting Injectables, Schizophrenia

    Continuing Nursing Education:
    1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    17th Annual Clinical Psychopharmacology Institute
    Louisville, KY
    Friday, June 7, 2019
    8:00am - 9:30am


    The contact hours for this session expire:  June 30, 2021

  • 102-19: Complex Issues in Pediatric Psychopharmacology: Depressive & Anxiety Disorders

    Contains 5 Component(s), Includes Credits

    Presenter: Jeffrey R. Strawn, MD, FAACAP 1.5 pharmacology contact hours

    102-19:  Complex Issues in Pediatric Psychopharmacology: Depressive & Anxiety Disorders

    This course explores a wealth of data and strategy to inform prescribing practices for children and adolescents with depressive and anxiety disorders. Through antidepressant efficacy and tolerability data, gain insight into how to best meet the pharmacological needs of this pediatric population.


    Presenter:  Jeffrey R. Strawn, MD, FAACAP 

    Disclosures: The speaker has indicated a significant financial interest or affiliation with Myriad/Assurex , CMEology, Kansas University, Current Psychiatry, and  Springer Publishing. The speaker also receives research funding from NIH, Allergan, Neuronetics, Shire, Edgemont and the Yung Family Foundation. Off-label use of medications will be discussed during this presentation.The activity planners have no conflicts of interest to disclose.


    Session Length:
      1 Hour 24 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Describe differences in efficacy and tolerability among antidepressant medications in pediatric patients with anxiety disorders.
    2. Describe individual differences in SSRI metabolism and exposure in pediatric patients and dosing implications.

    Keywords:  Psychopharmacology, Pediatrics


    Continuing Nursing Education:
    1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    17th Annual Clinical Psychopharmacology Institute
    Louisville, KY
    Friday, June 7, 2019
    9:45am - 11:15am


    The contact hours for this session expire:  June 30, 2021

  • 104-19: Sexuality and Psychotropics

    Product not yet rated Contains 5 Component(s), Includes Credits

    Presenter: Sattaria Dilks, DNP, APRN, PMHNP-BC 1.5 pharmacology contact hours

    104-19:  Sexuality and Psychotropics

    This presentation includes a candid discussion of the sexual side effects of psychotropic and non-psychotropic medications, that may interfere with consumer willingness to continue treatment. Hear eye opening cases to improve understanding and communication with the clients you serve.


    Presenter:   Sattaria Dilks, DNP, APRN, PMHNP-BC

    Disclosures:  The presenter has indicated a significant financial interest or other affiliation with Otsuka Speaker Bureau. Off-label use of medications will be discussed during this presentation.The activity planners have no conflicts of interest to disclose.


    Session Length:
      1 hour 22 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Discuss the impact of mental illness and commonly used psychiatric medications on sexuality. 
    2. Examine prescribing considerations related to psychiatric medications and adverse sexual issues and potential solutions to minimize pharmacologically based sexual issues.

    Keywords:  Psychopharmacology, Side Effects


    Continuing Nursing Education:
    1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    17th Annual Clinical Psychopharmacology Institute
    Louisville, KY
    Friday, June 7, 2019
    1:45pm - 3:15pm


    The contact hours for this session expire:  June 30, 2021